Published in Oral Oncol on June 22, 2006
Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity. J Occup Med Toxicol (2008) 0.95
Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro. Virol J (2009) 0.81
Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use. Antimicrob Agents Chemother (2015) 0.77
Triphenylmethane dye activation of beta-arrestin. Biochemistry (2013) 0.76
Color Stability of Nanofilled and Microhybrid Resin-Based Composites Following Exposure to Chlorhexidine Mouthrinses: An In Vitro Study. J Dent (Tehran) (2016) 0.75
Potential hazards due to food additives in oral hygiene products. J Istanb Univ Fac Dent (2016) 0.75
The role of actigraphy in the study of sleep and circadian rhythms. Sleep (2003) 10.70
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis (2006) 4.88
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis (2004) 2.89
Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med (2004) 2.86
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer (2008) 2.57
The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer (2003) 2.46
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother (2007) 2.10
Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer (2005) 2.04
Intravascular catheter-related infections: new horizons and recent advances. Arch Intern Med (2002) 1.94
Reducing metal artifacts in cone-beam CT images by preprocessing projection data. Int J Radiat Oncol Biol Phys (2006) 1.65
Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg (2012) 1.61
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am J Med (2002) 1.60
Clinical-use-associated decrease in susceptibility of vancomycin-resistant Enterococcus faecium to linezolid: a comparison with quinupristin-dalfopristin. Antimicrob Agents Chemother (2004) 1.58
Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore) (2009) 1.58
The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*. Crit Care Med (2014) 1.49
Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res (2003) 1.45
In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother (2003) 1.45
Improved serodetection of Mycobacterium bovis infection in badgers (Meles meles) using multiantigen test formats. Diagn Microbiol Infect Dis (2003) 1.45
International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother (2010) 1.35
Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother (2006) 1.30
Development and evaluation of a gamma-interferon assay for tuberculosis in badgers (Meles meles). Tuberculosis (Edinb) (2007) 1.16
Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. J Clin Oncol (2004) 1.13
Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer (2010) 1.12
Skin lesions associated with Fusarium infection. J Am Acad Dermatol (2002) 1.09
Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol (2011) 1.09
Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer (2010) 1.08
Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol (2003) 1.06
Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis (2002) 1.05
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer (2005) 1.04
Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results. Antimicrob Agents Chemother (2009) 1.02
Multilevel en bloc spondylectomy and chest wall excision via a simultaneous anterior and posterior approach for Ewing sarcoma. Spine (Phila Pa 1976) (2005) 1.02
Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg (2012) 1.01
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys (2004) 1.01
Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol (2002) 1.00
Nocardiosis in cancer patients. Medicine (Baltimore) (2002) 1.00
Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest (2002) 1.00
The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg (2003) 0.99
Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods. J Clin Microbiol (2009) 0.98
Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist (2011) 0.98
Vancomycin-resistant Enterococcus faecium: catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilm. Antimicrob Agents Chemother (2005) 0.96
A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. J Antimicrob Chemother (2004) 0.96
Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents (2008) 0.95
Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control (2006) 0.94
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem (2012) 0.94
Immunological responses and protective immunity in BCG vaccinated badgers following endobronchial infection with Mycobacterium bovis. Vaccine (2008) 0.94
Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med (2003) 0.94
Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? Cancer (2012) 0.93
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy. Cancer (2008) 0.93
Comparative in vitro efficacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother (2006) 0.93
Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol (2009) 0.93
Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore) (2007) 0.92
EDTA as an adjunct antifungal agent for invasive pulmonary aspergillosis in a rodent model. Antimicrob Agents Chemother (2006) 0.92
Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer (2011) 0.92
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys (2003) 0.92
Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys (2004) 0.89
Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms. Antimicrob Agents Chemother (2013) 0.89
RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection. Infect Immun (2004) 0.89
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists. Bioorg Med Chem Lett (2006) 0.89
Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol (2002) 0.89
Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer (2006) 0.89
An epidemiologic study of early onset lung cancer. Lung Cancer (2006) 0.88
Myelosuppression and serotonin syndrome associated with concurrent use of linezolid and selective serotonin reuptake inhibitors in bone marrow transplant recipients. Clin Infect Dis (2003) 0.88
Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis (2004) 0.87
Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration. Mol Ther (2003) 0.86
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents (2010) 0.86
Rhodococcus bacteremia in cancer patients is mostly catheter related and associated with biofilm formation. PLoS One (2012) 0.86
Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer. Cancer (2007) 0.86
Central venous catheter-associated Nocardia bacteremia in cancer patients. Emerg Infect Dis (2011) 0.86
Orthopaedic metal devices coated with a novel antiseptic dye for the prevention of bacterial infections. Int J Antimicrob Agents (2007) 0.85
The importance of two-step tuberculin skin testing for newly employed healthcare workers. Infect Control Hosp Epidemiol (2006) 0.85
Comparing quantitative culture of a blood sample obtained through the catheter with differential time to positivity in establishing a diagnosis of catheter-related bloodstream infection. Infect Control Hosp Epidemiol (2010) 0.84
Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens. Am J Infect Control (2009) 0.84
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13. Bioorg Med Chem Lett (2011) 0.84
Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol (2015) 0.84
Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance. Infect Control Hosp Epidemiol (2003) 0.84
Prospective study of the value of quantitative culture of organisms from blood collected through central venous catheters in differentiating between contamination and bloodstream infection. J Clin Microbiol (2006) 0.84
Impact of surveillance for vancomycin-resistant enterococci on controlling a bloodstream outbreak among patients with hematologic malignancy. Infect Control Hosp Epidemiol (2004) 0.83
Beta-lactams or gamma-lactams by 4-exo-trig or 5-endo-trig anionic cyclisation of lithiated acrylamide derivatives. Chem Commun (Camb) (2003) 0.83
Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care (2013) 0.83
Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis (2013) 0.83
Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg (2011) 0.83
Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control (2011) 0.83
Correlation between early clinical response after catheter removal and diagnosis of catheter-related bloodstream infection. Diagn Microbiol Infect Dis (2007) 0.83
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors. J Med Chem (2014) 0.82
Catheter-related vancomycin-resistant Enterococcus faecium bacteremia: clinical and molecular epidemiology. Infect Control Hosp Epidemiol (2005) 0.82
Antigen specific immunological responses of badgers (Meles meles) experimentally infected with Mycobacterium bovis. Vet Immunol Immunopathol (2007) 0.82